Win–Win Integration of Genetically Engineered Cellular Nanovesicles with High‐Absorbing Multimodal Phototheranostic Molecules for Boosted Cancer Photo‐Immunotherapy
Advanced Materials · 2025-04 · 37 (14)
DOI: 10.1002/adma.202416590 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 26.02.2025. Verfasst von Xue Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for AIE Research, Guangdong Provincial Key Laboratory of New Energy Materials Service Safety, College of Materials Science and Engineering, Sh…. Hauptthemen laut MEDLINE: Immunotherapy, Theranostic Nanomedicine, Genetic Engineering, Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, Start-up Grant from Shenzhen University.
Abstract (Originalsprache)
Photo‐immunotherapy is one of the most promising cancer treatment strategies. As immunotherapeutic agents, immune checkpoint blockade antibodies against programmed cell death protein 1 (PD‐1) or programmed cell death ligand 1 (PD‐L1) exhibit substantial potential, but have to face non‐specific distribution and the subsequent immune‐related adverse events. Meanwhile, high‐performance phototheranostic agents concurrently possessing multiple phototheranostic modalities and high light‐harvesting capacity are really attractive and highly desired as touching phototheranostic modules. Herein, a win–win strategy that integrates phototheranostic molecule design and targeted immunotherapeutic module preparation is developed to construct high‐powered photo‐immunotherapy systems. Specifically, the phototheranostic agent (AOTTIT) displaying typical aggregation‐induced fluorescence extending to the second near‐infrared II window, as well as outstanding reactive oxygen species and heat production capacity is first obtained via ingenious design. Notably, AOTTIT exhibits a record high molar extinction coefficient among the reported organic multimodal phototheranostic molecules. Meanwhile, PD‐1 genetically engineered cancer cell membrane‐derived nanovesicles (PD‐1/CMNVs) are prepared as both nanocarriers and immunotherapeutic agents to camouflage AOTTIT nanoparticles, yielding a multifunctional photo‐immunotherapeutic agent (CMNPs/PD‐1) with tumor‐specific active and homologous targeting ability. The distinct suppression of primary and metastatic lung tumors after only once treatment to the primary tumor substantiated the synergistically strengthened photo‐immunotherapeutic efficiency of this win‐win strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for AIE Research, Guangdong Provincial Key Laboratory of New Energy Materials Service Safety, College of Materials Science and Engineering, Shenzhen University, Shenzhen, 518060, P. R. China.
- Department of Chemistry, Hong Kong Branch of Chinese National Engineering Research Center for Tissue Restoration and Reconstruction, Guangdong-Hong Kong-Macau Joint Laboratory of Optoelectronic and Magnetic Functional M…
- School of Science and Engineering, Shenzhen Institute of Aggregate Science and Technology, The Chinese University of Hong Kong, Shenzhen (CUHK-Shenzhen), Guangdong, 518172, China.
ORCID-Profile: Ben Zhong Tang
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Start-up Grant from Shenzhen University
Zitieren
APA
Li, X., Ou, X., Yang, Z., Kang, M., Xu, W., Li, D., Kwok, R. T. K., Lam, J. W. Y., Zhang, Z., Wang, D., & Tang, B. Z. (2025). Win–Win Integration of Genetically Engineered Cellular Nanovesicles with High‐Absorbing Multimodal Phototheranostic Molecules for Boosted Cancer Photo‐Immunotherapy. Advanced Materials, 37(14). https://doi.org/10.1002/adma.202416590
Vancouver
Li X, Ou X, Yang Z, Kang M, Xu W, Li D, et al. Win–Win Integration of Genetically Engineered Cellular Nanovesicles with High‐Absorbing Multimodal Phototheranostic Molecules for Boosted Cancer Photo‐Immunotherapy. Advanced Materials. 2025;37(14). doi:10.1002/adma.202416590
BibTeX
@article{Li2025,
author = {Li, Xue and Ou, Xinwen and Yang, Zengming and Kang, Miaomiao and Xu, Weilin and Li, Danxia and Kwok, Ryan T K and Lam, Jacky W Y and Zhang, Zhijun and Wang, Dong and Tang, Ben Zhong},
title = {Win–Win Integration of Genetically Engineered Cellular Nanovesicles with High‐Absorbing Multimodal Phototheranostic Molecules for Boosted Cancer Photo‐Immunotherapy},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {14},
doi = {10.1002/adma.202416590}
}
EUVIMED